SCHEMBL25918428

SCHEMBL25918428

CBc1ccc(OC)cc1O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 3/20 0.50
▸ RAB9A P51151 2/20 0.50
▸ ALDH1A1 P00352 3/20 0.48
▸ CYP3A4 P08684 3/20 0.48
▸ MAPK1 P28482 3/20 0.48
▸ HPGD P15428 3/20 0.48
▸ TRIM24 O15164 1/20 0.48
▸ TYR P14679 1/20 0.48
▸ TRIM33 Q9UPN9 1/20 0.48
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ KDM4E B2RXH2 2/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ GAA P10253 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ THRB P10828 1/20 0.47
▸ RECQL P46063 1/20 0.47
▸ BLM P54132 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ MCL1 Q07820 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10053462 0.77 CA12 (0.42) RAB9AALDH1A1HPGDKDM4EMEN1
SCHEMBL12164545 0.75 CYP1A2 (0.43) NPC1RAB9AALDH1A1MAPK1SMN1; SMN2
SCHEMBL67498 0.75 ALDH1A1 (0.61) NPC1RAB9AALDH1A1CYP3A4MAPK1
SCHEMBL29950410 0.75 ALDH1A1 (0.61) NPC1RAB9AALDH1A1CYP3A4MAPK1
SCHEMBL340086 0.75 NPC1 (0.60) NPC1RAB9AALDH1A1CYP3A4MAPK1
SCHEMBL929945 0.71 CYP3A4 (0.56) NPC1RAB9AALDH1A1CYP3A4MAPK1
SCHEMBL581508 0.71 TUBB4A (0.63) NPC1RAB9AALDH1A1CYP3A4MAPK1
SCHEMBL12809824 0.71 ERN1 (0.41) NPC1RAB9AALDH1A1CYP3A4TRIM24
SCHEMBL1620598 0.70 NPC1 (0.53) NPC1RAB9AALDH1A1CYP3A4MAPK1
SCHEMBL1000565 0.70 NPC1 (0.53) NPC1RAB9AALDH1A1CYP3A4MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023141432-A2 APOL1 INHIBITORS AND METHODS OF USE MAZE THERAPEUTICS, INC. (US) 2023-07-27 — — WO disclosed
Send feedback